XML 24 R13.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Supplemental Equity and Accumulated Other Comprehensive Income (loss) Information | 6 Months Ended
--- | ---
Dec. 31, 2024
Notes to Financial Statements |
Supplemental Equity and Accumulated Other Comprehensive Income (loss) Information | Note 8. Supplemental Equity and Accumulated Other Comprehensive Income (Loss): ​ Supplemental Equity ​ The Company has declared cash dividends per share of $0.08 and $0.16 in the three and six months ended December 31, 2024 and 2023, respectively. ​ Consolidated Changes in Equity (amounts in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Bio-Techne Shareholders |  | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Accumulated | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | Additional | ​ | ​ | ​ | ​ | Other | ​ | ​ | ​
​ | ​ | Common Stock | ​ | Paid-in | ​ | Retained | ​ | Comprehensive | ​ | ​
​ | ​ | Shares | ​ | Amount | ​ | Capital | ​ | Earnings | ​ | Income(Loss) | ​ | Total
Balances at June 30, 2024 |  | 158,216 | ​ | $ | 1,582 | ​ | $ | 820,337 | ​ | $ | 1,325,247 | ​ | $ | (78,316) | ​ | $ | 2,068,850
Net earnings |  | ​ | ​ | ​ | ​ | ​ |  | ​ | ​ |  | 33,600 | ​ |  | ​ | ​ |  | 33,600
Other comprehensive income (loss) |  | ​ | ​ | ​ | ​ | ​ |  | ​ | ​ |  | ​ | ​ |  | 18,229 | ​ |  | 18,229
Common stock issued for exercise of options |  | 577 | ​ |  | 6 | ​ |  | 23,224 | ​ |  | (2,338) | ​ |  | ​ | ​ |  | 20,892
Common stock issued for restricted stock awards |  | 50 | ​ | ​ | 1 | ​ |  | 1 | ​ |  | (2,646) | ​ |  | ​ | ​ |  | (2,644)
Cash dividends |  | ​ | ​ | ​ | ​ | ​ |  | ​ | ​ |  | (12,688) | ​ |  | ​ | ​ |  | (12,688)
Stock-based compensation expense |  | ​ | ​ |  | ​ | ​ |  | 10,146 | ​ |  | ​ | ​ |  | ​ | ​ |  | 10,146
Common stock issued to employee stock purchase plan |  | 35 | ​ | ​ | 0 | ​ |  | 2,227 | ​ |  | ​ | ​ |  | ​ | ​ |  | 2,227
Employee stock purchase plan expense | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 38 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 38
Balances at September 30, 2024 |  | 158,878 | ​ | $ | 1,589 | ​ | $ | 855,973 | ​ | $ | 1,341,175 | ​ | $ | (60,087) | ​ | $ | 2,138,650
Net earnings |  | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 34,890 | ​ | ​ | ​ | ​ |  | 34,890
Other comprehensive income (loss) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (25,563) | ​ | ​ | (25,563)
Share repurchases |  | (1,118) | ​ | ​ | (11) | ​ | ​ | ​ | ​ | ​ | (75,617) | ​ | ​ | ​ | ​ |  | (75,628)
Common stock issued for exercise of options |  | 132 | ​ | ​ | 1 | ​ | ​ | 5,183 | ​ | ​ | (20) | ​ | ​ | ​ | ​ |  | 5,164
Common stock issued for restricted stock awards |  | 24 | ​ | ​ | 0 | ​ | ​ | 0 | ​ | ​ | (993) | ​ | ​ | ​ | ​ |  | (993)
Cash dividends |  | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (12,736) | ​ | ​ | ​ | ​ |  | (12,736)
Stock-based compensation expense |  | ​ | ​ | ​ | ​ | ​ | ​ | 14,335 | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | 14,335
Employee stock purchase plan expense | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 373 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 373
Balances at December 31, 2024 |  | 157,916 | ​ | $ | 1,579 | ​ | $ | 875,864 | ​ | $ | 1,286,699 | ​ | $ | (85,650) | ​ | $ | 2,078,492
​ ​ ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Bio-Techne Shareholders |  |  | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Accumulated | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | Additional | ​ | ​ | ​ | ​ | Other | ​ | ​ | ​
​ | ​ | Common Stock | ​ | Paid-in | ​ | Retained | ​ | Comprehensive | ​ | ​ | ​
​ | ​ | Shares | ​ | Amount | ​ | Capital | ​ | Earnings | ​ | Income(Loss) | ​ | Total
Balances at June 30, 2023 |  | 157,642 | ​ | $ | 1,576 | ​ | $ | 721,543 | ​ | $ | 1,309,461 | ​ | $ | (66,064) | ​ | $ | 1,966,516
Net earnings |  | ​ | ​ | ​ | ​ | ​ |  | ​ | ​ |  | 50,993 | ​ |  | ​ | ​ |  | 50,993
Other comprehensive income (loss) |  | ​ | ​ | ​ | ​ | ​ |  | ​ | ​ |  | ​ | ​ |  | (11,952) | ​ |  | (11,952)
Common stock issued for exercise of options |  | 633 | ​ |  | 6 | ​ |  | 12,877 | ​ |  | (15,460) | ​ |  | ​ | ​ |  | (2,577)
Common stock issued for restricted stock awards |  | 47 | ​ | ​ | 1 | ​ |  | 0 | ​ |  | (4,768) | ​ |  | ​ | ​ |  | (4,767)
Cash dividends |  | ​ | ​ | ​ | ​ | ​ |  | ​ | ​ |  | (12,654) | ​ |  | ​ | ​ |  | (12,654)
Stock-based compensation expense |  | ​ | ​ |  | ​ | ​ |  | 9,981 | ​ |  | ​ | ​ |  | ​ | ​ |  | 9,981
Common stock issued to employee stock purchase plan |  | 33 | ​ | ​ | 1 | ​ |  | 2,093 | ​ |  | ​ | ​ |  | ​ | ​ |  | 2,094
Employee stock purchase plan expense | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 112 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 112
Balances at September 30, 2023 |  | 158,355 | ​ | $ | 1,584 | ​ | $ | 746,606 | ​ | $ | 1,327,572 | ​ | $ | (78,016) | ​ | $ | 1,997,746
Net earnings |  | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 27,465 | ​ | ​ | ​ | ​ |  | 27,465
Other comprehensive income (loss) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 14,355 | ​ | ​ | 14,355
Share repurchases |  | (1,397) | ​ | ​ | (14) | ​ | ​ | ​ | ​ | ​ | (80,028) | ​ | ​ | ​ | ​ |  | (80,042)
Common stock issued for exercise of options |  | 157 | ​ | ​ | 1 | ​ | ​ | 4,914 | ​ | ​ | (1,074) | ​ | ​ | ​ | ​ |  | 3,841
Common stock issued for restricted stock awards |  | 27 | ​ | ​ | 0 | ​ | ​ | 0 | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | 0
Cash dividends |  | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (12,559) | ​ | ​ | ​ | ​ |  | (12,559)
Stock-based compensation expense |  | ​ | ​ | ​ | ​ | ​ | ​ | 12,413 | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | 12,413
Employee stock purchase plan expense | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 340 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 340
Balances at December 31, 2023 |  | 157,142 | ​ | $ | 1,571 | ​ | $ | 764,273 | ​ | $ | 1,261,376 | ​ | $ | (63,661) | ​ | $ | 1,963,559
​ ​ Accumulated Other Comprehensive Income The components of Other comprehensive income (loss) consist of changes in foreign currency translation adjustments and changes in net unrealized gains (losses) on derivative instruments designated as cash flow hedges. The accumulated balances related to each component of Other comprehensive income (loss) are summarized as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Three months ended December 31, 2024 (in thousands): | ​ | Unrealized | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Gains | ​ | Foreign | ​ | ​ | ​
​ | ​ | (Losses) on | ​ | Currency | ​ | ​ | ​
​ | ​ | Derivative | ​ | Translation | ​ | ​ | ​
​ |  | Instruments |  | Adjustments |  | Total
Balance as of September 30, 2024, net of tax | ​ | $ | 5,075 | ​ | $ | (65,162) | ​ | $ | (60,087)
Other comprehensive income (loss), before tax: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Amounts before reclassifications | ​ | ​ | (1,689) | ​ | ​ | (26,021) | ​ | ​ | (27,710)
Amounts reclassified out | ​ | ​ | 2,155 | ​ | ​ | 660 | ​ | ​ | 2,815
Total other comprehensive income (loss), before tax | ​ | ​ | 466 | ​ | ​ | (25,361) | ​ | ​ | (24,895)
Tax (expense)/benefit | ​ | ​ | (511) | ​ | ​ | (157) | ​ | ​ | (668)
Total other comprehensive income (loss), net of tax | ​ |  | (45) | ​ | ​ | (25,518) | ​ | ​ | (25,563)
Balance as of December 31, 2024, net of tax | ​ | $ | 5,030 | ​ | $ | (90,680) | ​ | $ | (85,650)
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Three months ended December 31, 2023 (in thousands): | ​ | Unrealized | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Gains | ​ | Foreign | ​ | ​ | ​
​ | ​ | (Losses) on | ​ | Currency | ​ | ​ | ​
​ | ​ | Derivative | ​ | Translation | ​ | ​ | ​
​ |  | Instruments |  | Adjustments |  | Total
Balance as of September 30, 2023 net of tax: | ​ | $ | 12,512 | ​ | $ | (90,528) | ​ | $ | (78,016)
Other comprehensive income (loss), before tax: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Amounts before reclassifications | ​ | ​ | (5,669) | ​ | ​ | 17,387 | ​ | ​ | 11,718
Amounts reclassified out | ​ | ​ | 2,620 | ​ | ​ | 837 | ​ | ​ | 3,457
Total other comprehensive income (loss), before tax | ​ | ​ | (3,049) | ​ | ​ | 18,224 | ​ | ​ | 15,175
Tax (expense)/benefit | ​ | ​ | (621) | ​ | ​ | (199) | ​ | ​ | (820)
Total other comprehensive income (loss), net of tax | ​ |  | (3,670) | ​ | ​ | 18,025 | ​ | ​ | 14,355
Balance as of December 31, 2023, net of tax | ​ | $ | 8,842 | ​ | $ | (72,503) | ​ | $ | (63,661)
​ ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Six months ended December 31, 2024 (in thousands): | ​ | Unrealized | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Gains | ​ | Foreign | ​ | ​ | ​
​ | ​ | (Losses) on | ​ | Currency | ​ | ​ | ​
​ | ​ | Derivative | ​ | Translation | ​ | ​ | ​
​ |  | Instruments |  | Adjustments |  | Total
Balance as of June 30, 2024, net of tax: | ​ | $ | 8,102 | ​ | $ | (86,418) | ​ | $ | (78,316)
Other comprehensive income (loss), before tax: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Amounts before reclassifications | ​ | ​ | (6,699) | ​ | ​ | (5,362) | ​ | ​ | (12,061)
Amounts reclassified out | ​ | ​ | 4,754 | ​ | ​ | 1,442 | ​ | ​ | 6,196
Total other comprehensive income (loss), before tax | ​ | ​ | (1,945) | ​ | ​ | (3,920) | ​ | ​ | (5,865)
Tax (expense)/benefit | ​ | ​ | (1,127) | ​ | ​ | (342) | ​ | ​ | (1,469)
Total other comprehensive income (loss), net of tax | ​ |  | (3,072) | ​ | ​ | (4,262) | ​ | ​ | (7,334)
Balance as of December 31, 2024, net of tax(1) | ​ | $ | 5,030 | ​ | $ | (90,680) | ​ | $ | (85,650)
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Six months ended December 31, 2023 (in thousands): | ​ | Unrealized | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Gains | ​ | Foreign | ​ | ​ | ​
​ | ​ | (Losses) on | ​ | Currency | ​ | ​ | ​
​ | ​ | Derivative | ​ | Translation | ​ | ​ | ​
​ |  | Instruments |  | Adjustments |  | Total
Balance as of June 30, 2023, net of tax: | ​ | $ | 12,862 | ​ | $ | (78,926) | ​ | $ | (66,064)
Other comprehensive income (loss), before tax: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Amounts before reclassifications | ​ | ​ | (7,956) | ​ | ​ | 5,252 | ​ | ​ | (2,704)
Amounts reclassified out | ​ | ​ | 5,159 | ​ | ​ | 1,535 | ​ | ​ | 6,694
Total other comprehensive income (loss), before tax | ​ | ​ | (2,797) | ​ | ​ | 6,787 | ​ | ​ | 3,990
Tax (expense)/benefit | ​ | ​ | (1,223) | ​ | ​ | (364) | ​ | ​ | (1,587)
Total other comprehensive income (loss), net of tax | ​ |  | (4,020) | ​ | ​ | 6,423 | ​ | ​ | 2,403
Balance as of December 31, 2023, net of tax(1) | ​ | $ | 8,842 | ​ | $ | (72,503) | ​ | $ | (63,661)
​ (1) The Company had a net deferred tax liability for its cash flow hedge of $1.6 million and $2.7 million as of December 31, 2024 and 2023, respectively. ​ Income taxes are not provided for foreign translation relating to permanent investments in international subsidiaries, but tax effects within foreign currency translation adjustments do include impacts from the net investment hedge.

X
- Definition The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(19)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(21)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(23)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/220/tableOfContent + Details
Name: | us-gaap_ComprehensiveIncomeNoteTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration